Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique

被引:102
作者
Kohri, N
Yamayoshi, Y
Xin, H
Iseki, K
Sato, N
Todo, S
Miyazaki, K
机构
[1] Hokkaido Univ, Sch Med, Hokkaido Univ Hosp, Dept Pharm,Kita Ku, Sapporo, Hokkaido 0608648, Japan
[2] Hokkaido Univ, Sch Med, Hokkaido Univ Hosp, Dept Surg 1,Kita Ku, Sapporo, Hokkaido 0608648, Japan
[3] Hokkaido Univ, Coll Pharm, Dept Pharm, Kita Ku, Sapporo, Hokkaido 0608648, Japan
关键词
D O I
10.1211/0022357991772277
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have investigated the oral bioavailability of granules of albendazole, a drug used for treating echinococcosis in man, prepared by the solid dispersion technique. Rapid dissolution and supersaturation were observed when hydroxypropylmethyl cellulose and hydroxypropylmethylcellulose phthalate were used as carriers in the solid dispersion. They inhibited the crystallization of albendazole from the supersaturated solution and maintained an amorphous state for 8h. Gastric acidity-controlled rabbits were used to evaluate the variation in absorption after oral administration of the albendazole solid dispersion. For rabbits with low gastric acidity the bioavailability of orally administered albendazole in the granular form prepared by solid dispersion was more than three times that of albendazole in physical mixtures. These results suggest that the bioavailability of albendazole in solid dispersions might be high even if there is a great variation in the gastric pH of patients.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 18 条
[1]   INCREASED SYSTEMIC BIOAVAILABILITY OF ALBENDAZOL WHEN ADMINISTERED WITH SURFACTANTS IN RATS [J].
DELESTAL, JL ;
ALVAREZ, AI ;
VILLAVERDE, C ;
JUSTEL, A ;
PRIETO, JG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 102 (1-3) :257-260
[2]  
HONBO T, 1987, TRANSPLANT P, V19, P17
[3]   Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery [J].
Ishizu, H ;
Uchino, J ;
Sato, N ;
Aoki, S ;
Suzuki, K ;
Kuribayashi, H .
HEPATOLOGY, 1997, 25 (03) :528-531
[4]   CLINICAL PHARMACOKINETICS OF ALBENDAZOLE IN PATIENTS WITH BRAIN CYSTICERCOSIS [J].
JUNG, H ;
HURTADO, M ;
SANCHEZ, M ;
MEDINA, MT ;
SOTELO, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (01) :28-31
[5]   ORAL ABSORPTION OF FK506 IN RATS [J].
KAGAYAMA, A ;
TANIMOTO, S ;
FUJISAKI, J ;
KAIBARA, A ;
OHARA, K ;
IWASAKI, K ;
HIRANO, Y ;
HATA, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (10) :1446-1450
[6]   EVALUATION OF PH-INDEPENDENT SUSTAINED-RELEASE GRANULES OF DIPYRIDAMOLE BY USING GASTRIC-ACIDITY-CONTROLLED RABBITS AND HUMAN-SUBJECTS [J].
KOHRI, N ;
MIYATA, N ;
TAKAHASHI, M ;
ENDO, H ;
ISEKI, K ;
MIYAZAKI, K ;
TAKECHI, S ;
NOMURA, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 81 (01) :49-58
[7]  
Kohri N., 1998, Pharmacy and Pharmacology Communications, V4, P267
[8]   IMPROVED ORAL ABSORPTION OF ENTERIC COPRECIPITATES OF A PEARLY SOLUBLE DRUG [J].
KONDO, N ;
IWAO, T ;
HIRAI, K ;
FUKUDA, M ;
YAMANOUCHI, K ;
YOKOYAMA, K ;
MIYAJI, M ;
ISHIHARA, Y ;
KON, K ;
OGAWA, Y ;
MAYUMI, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (04) :566-570
[9]   MANAGEMENT OF HYDATID-DISEASE OF THE LIVER [J].
KUMAR, A ;
CHATTOPADHYAY, TK .
POSTGRADUATE MEDICAL JOURNAL, 1992, 68 (805) :853-856
[10]   INCREASED SYSTEMIC AVAILABILITY OF ALBENDAZOLE WHEN TAKEN WITH A FATTY MEAL [J].
LANGE, H ;
EGGERS, R ;
BIRCHER, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (03) :315-317